Drug Profile
QR 111
Alternative Names: QR111Latest Information Update: 28 Sep 2021
Price :
$50
*
At a glance
- Originator Qrono
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - Musculoskeletal disorders
Highest Development Phases
- No development reported Musculoskeletal disorders
Most Recent Events
- 28 Sep 2021 No recent reports of development identified for research development in Musculoskeletal-disorders in USA (Parenteral, Injection)
- 22 Aug 2017 QR 111 is available for licensing as of 22 Aug 2017. http://qrono.com/pipeline/
- 22 Aug 2017 Early research in Musculoskeletal disorders in USA (Parenteral) (Qrono pipeline, August 2017)